欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IT/V/0132/001
药品名称API-BIOXAL, 886 mg/g, powder for in-hive-use
活性成分
    • oxalic acid 886.0 mg/g
剂型Bee-hive dispersion in sachet
上市许可持有人Chemicals Laif V.le dell’Artigianato 13, 35010 Vigonza (PD) – Italy
参考成员国 - 产品名称Italy (IT)
Api-bioxal, 886mg/g, polvere per alveare - the renewal is administrative
互认成员国 - 产品名称
    • Spain (ES)
      API-BIOXAL 886 mg/g polvo para uso en colmenas
    • Ireland (IE)
      API-BIOXAL Oxalic acid dihydrate 886.0mg/g Powder and Solution for bee-hive solution
    • Norway (NO)
    • Bulgaria (BG)
    • Romania (RO)
    • Croatia (HR)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
    • France (FR)
    • Portugal (PT)
    • Slovenia (SI)
许可日期2015/05/20
最近更新日期2021/06/02
药物ATC编码
    • QP53AG03 oxalic acid
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase